Two cardenolide glycosides from the seed fairs of Asclepias curassavica and their cytotoxic activities.
10.1016/S1875-5364(21)60098-5
- Author:
Ai-Jia JI
1
;
Qing MA
2
;
Mu-Yan KONG
1
;
Le-Yan LI
1
;
Xin-Lian CHEN
3
;
Zhong-Qiu LIU
1
;
Jin-Jun WU
4
;
Rong-Rong ZHANG
5
Author Information
1. Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
2. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Shenzhen 518110, China.
3. School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China.
4. Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China. Electronic address: wujinjun@gzucm.edu.cn.
5. Joint Laboratory for Translational Cancer Research of Chinese Medicine of the Ministry of Education of the People's Republic of China, School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China. Electronic address: zrr586@gzucm.edu.cn.
- Publication Type:Journal Article
- Keywords:
Asclepias curassavica;
Cardenolide glycosides;
Cytotoxic activity;
Structure identification
- MeSH:
Antineoplastic Agents/pharmacology*;
Asclepias/chemistry*;
Cardenolides/pharmacology*;
Glycosides/pharmacology*;
Humans;
Seeds
- From:
Chinese Journal of Natural Medicines (English Ed.)
2022;20(3):202-209
- CountryChina
- Language:English
-
Abstract:
Two cardenolide glycosides, corotoxigenin 3-O-[β-D-glucopyranosyl-(1→4)-6-deoxy-β-D-glucopyranoside] (1) and coroglaucigenin 3-O-[β-D-glucopyranosyl-(1→4)-6-deoxy-β-D-glucopyranoside] (2), were isolated from the seed fairs of Asclepias curassavica. The structures of 1-2 were determined based on the combination of the analysis of their MS, NMR spectroscopic data and acid hydrolysis. The inhibitory effects of compounds 1 and 2 on human colorectal carcinoma cells (HCT116), non-small cell lung carcinoma cells (A549) and hepatic cancer cells (SMMC-7721) were evaluated. The results showed that both compounds 1 and 2 significantly inhibited the viability, proliferation, and migration of A549, HCT116 and SMMC-7721 cells, suggesting that compounds 1 and 2 can be applied in the treatment of lung, colon and liver cancers in clinical practice. This study may not only provide a scientific basis for clarifying the active ingredients in A. curassavica, but also help to understand its antitumor activity, which can promote the application of A. curassavica in clinical treatment of various cancers.
